Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

CBD-DACannabidiol diacetate

Semi-synthetic acetic diester of CBD, a research analogue found in grey-market products.

Level of detail

C₂₅H₃₄O₄

CAS 40525-15-3

Family
Semi-synthetic cannabinoidEster or prodrug
Molar mass
398.54 g/mol

Updated on

In plain terms

Cannabidiol diacetate is chemically modified CBD: its two "OH" groups are turned into acetates. It was tested in animals as early as 1981 and was found in 2022 in products sold without oversight in the United States. Its effects in humans have never been studied.

Receptors and activity

    Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

    Measured effects

    Not characterised. No placebo-controlled human trial has measured the effects of CBD-DA, so no level is shown.

    Levels computed from placebo-controlled human trials: difference from placebo on 100, at the dose and route stated. Read the method

    Pharmacology

    Cannabidiol diacetate (CBD-DA) is the acetic diester of cannabidiol, in which both phenol functions of the resorcinol ring are acetylated. Consroe et al. (1981) compared it with CBD in rats: given intravenously, it was as effective as CBD against audiogenic seizures, with lower rotarod neurotoxicity, and inactive in rabbits susceptible to THC-induced seizures. Morales et al. (2017) suggest these diacetates might behave as CBD prodrugs, a hypothesis no measurement has verified. Holt et al. (2022) reported the first identification of this compound in commercial products, plant material and gummies that also contained Δ8-THC and THC acetates, in a case involving hallucinations. No receptor binding, pharmacokinetic or human safety data have been published.

    History

    Source
    Absent from cannabis: it is the acetic diester of cannabidiol, both of whose phenol functions are acetylated. It served as an analogue in pharmacological research (Consroe et al. 1981) and has been identified in grey-market products in the United States (Holt et al. 2022).

    Route of preparation

    Chemical process

    No plant pathway. It is a semi-synthetic acetic diester of cannabidiol, described here by chemical class only.

    Classification

    Family, origin and source verification

    Family

    Semi-synthetic cannabinoid › Ester or prodrug

    Chemistry

    C5 side chain · neutral form

    Verification

    Every fact on this entry was checked against its primary sources on 20 October 2026.

    Wikipedia (English)

    Cannabidiol diacetate (new tab)

    Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

    References

    Identifiers

    Names

    Common name
    Cannabidiol diacetate
    IUPAC name
    [3-acetyloxy-2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylphenyl] acetate
    Other names
    CBD-DA

    Identifiers

    Formula
    C₂₅H₃₄O₄
    CAS
    40525-15-3
    InChIKey
    UCYSPYOYJNVCAI-FCHUYYIVSA-N
    SMILES
    CCCCCC1=CC(=C(C(=C1)OC(=O)C)[C@@H]2C=C(CC[C@H]2C(=C)C)C)OC(=O)C

    Machine-readable entry (JSON)

    LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.